Quarterly report pursuant to Section 13 or 15(d)

Summary Significant Accounting Policies Parentheticals (Details)

v2.4.0.8
Summary Significant Accounting Policies Parentheticals (Details) (USD $)
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Summary Significant Accounting Policies Parentheticals    
Amortization of deferred financing costs related to convertible debt $ 0 $ 8,570
Costs of patents written off (ProAlgaZyme) 6,234  
Research Expenses - Salaries and equipment related expenses 66,734 71,493
Clinical Studies expenses - fees, charges and related expenses 373,631 233,975
Compensation expenses recorded 264,024 21,441
Advertising/Public Relation costs charged to operating expenses $ 12,341 $ 17,419